A CLINICAL STUDY TO FIND THE EFFECT OF TRIPHALADI KASHAYAM WITH INCREASED MICROALBUMINURIA LEVELS IN TYPE II DIABETES MELLITUS

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF TRIPHALADI KASHAYAM ON MICROALBUMINURIA LEVELS IN TYPE II DIABETES MELLITUS (MADHUMEHA) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072972

Enrollment

Registered

2024-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: H/O Type II Diabetes Mellitus Microalbuminuria levels between 30 to 299 mg/dl HbA1c more than 6.5%

Exclusion criteria

Exclusion criteria: Patient with Age below 18 and above 75 years Patient with H/O Type 1 DM Type II DM on insulin therapy Type II DM along with hypertension and under Anti-hypertensive Medication Microalbuminuria levels more than 300 mg/dl Pregnant and lactating mothers Microalbuminuria induced due to other diseases – Pregnancy, CKD Patient with other complication of DM–Ketoacidosis, Diabetic nephropathy Any other Systemic illness

Design outcomes

Primary

Measure	Time frame
Reduction in Microalbuminuria levels Timepoint: criteria will be assessed on 31st days	—

Secondary

Measure	Time frame
Reduction in FBS and PPBS levels Reduction in symptoms like Prabhoot Mutrata Pipasaadhikya Kshudhaadhikya KlamaTimepoint: criteria will be assessed on 31st days	—

Countries

India

Contacts

Public ContactDr Vipin S G

Sri Jayendra Saraswathi Ayurveda College and Hospital

drvipinsg@sjsach.org.in8547626217

Outcome results